Releases

Media coverage

Newsletter

Subscribe to our newsletter

Archive


Apr 27, 2016

Title: The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade

Authors: T Yamazaki, JM Pitt, M Vétizou, A Marabelle, C Flores, Ø Rekdal, G Kroemer and L Zitvogel

This preclinical study further provides strong rationale for combining LTX-315 with checkpoint inhibitor anti CTLA4.

Read the article